Biotech Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy October 20, 2026
Biotech Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania October 20, 2026
Biotech Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch October 20, 2026
Biotech Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting October 19, 2026
Biotech CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM October 19, 2026
Biotech Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026 October 19, 2026
Biotech Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA August 31, 2026
Biotech Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations August 31, 2026
Biotech AMGEN’S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE August 31, 2026
Biotech BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea August 30, 2026
Search
Biotech
October 20, 2026
October 20, 2026
October 20, 2026
October 19, 2026
October 19, 2026
October 19, 2026
August 31, 2026
August 31, 2026
August 31, 2026
August 30, 2026
